Cooper Companies Stock Plummets on Revenue Miss, Weak Guidance, and Canceled Unit Sale

Shares of Cooper Companies (COO) plunged 15.3% in pre-market trading Thursday after the company announced a trio of negative developments, including a revenue miss, a significant guidance reduction, and the surprise termination of a strategic review for its CooperSurgical unit.

Disappointing Results and Outlook

After the market closed Wednesday, Cooper Companies reported fiscal third-quarter 2026 revenue of $1.07 billion, falling short of the analyst consensus of $1.1 billion. While adjusted earnings per share of $1.15 narrowly beat estimates, this positive was overshadowed by the company's forward-looking statements.

Management issued fourth-quarter revenue guidance in the range of $1.057 billion to $1.080 billion, well below the approximately $1.12 billion Wall Street had anticipated. This new forecast implies organic growth of just 0% to 2%, with the company citing an inventory reduction in CooperVision's U.S. channel as a key headwind. According to a report from Investing.com, this marks the fourth time in two years the company has reduced its guidance.

Strategic Review Concludes Without a Sale

Compounding the financial disappointment, Cooper's board of directors announced it had unanimously voted to end a strategic review of its CooperSurgical division that began in December 2025. The company will retain the unit, stating that offers from potential buyers did not adequately reflect its value. The decision was influenced in part by the emergence of a new competitor in the non-hormonal IUD market.

Ad

The conclusion of the review without a sale removes a potential catalyst that some investors had hoped would unlock value. In response to the news, at least two investment banks downgraded the stock:

• Piper Sandler cut its rating to Neutral from Overweight and lowered its price target to $59 from $86.
• Baird moved its rating to Neutral from Outperform, reducing its price target to $61 from $85.

Market Context

The sharp sell-off appears to be entirely company-specific, as the broader S&P 500 and Dow Jones indices were trading near flat in the pre-market session. While Cooper Companies announced an expansion of its share repurchase authorization to $3 billion and posted a record quarterly free cash flow of $273 million, these positive factors were not enough to offset the negative impact of the revenue miss, guidance cut, and canceled sale.